Ignite Creation Date:
2025-12-25 @ 4:16 AM
Ignite Modification Date:
2026-02-09 @ 4:40 PM
Study NCT ID:
NCT02917720
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-22
First Post:
2016-03-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients
Sponsor:
European LeukemiaNet
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-02
First Submit QC Date:
None
Study First Post Date:
2016-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-19
Last Update Post Date:
2025-09-22
Last Update Post Date Type:
ESTIMATED